• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

1991-2000 VMAC Meeting Materials

horse, cow, birds, dog, cat, fish, pig, and chicken on a fence post with a blue background

 
-
-

November 1997

To discuss issues relating to the manufacture of animal drugs

-
-

Spring 1997 (May 14, 1997)

Define clinical ineffectiveness and describe how a veterinarian would determine it exists under the proposed regulations for the Animal Drug Use Clarification Act (AMDUCA).

-
-

Fall 1996 (November 20, 1996)

To review results of Monsanto's Post-Approval Monitoring Program (PAMP) for POSILAC (bST; sometribove), and findings from the commercial use of POSILAC.

-
-

Spring 1996 (May 29, 1996)

To discuss FDA Strategy to Address Animal Drug Residues in Milk, and POSILAC (bST; sometribove) Post Approval Monitoring Program and Adverse Drug Experience (ADE) Reporting.

-
-

Spring 1993 - March 31, 1993

Persons using assistive technology may not be able to fully access information in these documents. For assistance, please call 240-276-9300.

-